PathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The company's approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from complex samples in three hours. PathoGenetiX is developing its GSS platform for use in genomics research, food and product safety testing, and clinical infectious disease diagnostics, with initial commercial introduction into the research market planned for 2012.
Current Team (4)Update
Funding Rounds (5) - $24MUpdate
Board Members and Advisors (5)Update
AHV was established in 2001 by Ascension Health with a commitment of $125 million to invest in...
Excel Venture Management builds companies that apply transformative life science technologies to...
Venture capital Firm
CB Health Ventures manages $150 million of private equity funds focused on investment...
12 Gill Street
Woburn, MA 01801